Supramox

Supramox is a brand of amoxicillin, a moderate-spectrum, semi-synthetic aminopenicillin antibiotic marketed by Nutramedica. It is a small molecule that exerts its antibacterial effect by binding to and inhibiting penicillin-binding proteins (PBPs) located on the inner membrane of the bacterial cell wall. These proteins are essential for the final stages of peptidoglycan synthesis; their inhibition leads to the weakening of the cell wall and subsequent osmotic lysis of the bacteria. Supramox is administered orally and is indicated for a variety of bacterial infections, including respiratory tract infections, otitis media, sinusitis, and urinary tract infections, and is available in formulations suitable for both adult and pediatric use.

Brand names

Supramox

Other names

amoxicillin